- Report
- August 2025
- 190 Pages
Global
From €3496EUR$3,939USD£3,009GBP
Dihydrostreptomycin is an antibiotic used to treat bacterial infections. It is a semi-synthetic derivative of streptomycin, a natural antibiotic produced by the soil bacterium Streptomyces griseus. Dihydrostreptomycin is used to treat a variety of bacterial infections, including those of the urinary tract, respiratory tract, and skin. It is also used to treat certain types of meningitis. Dihydrostreptomycin is usually administered intravenously or intramuscularly.
Dihydrostreptomycin is a widely used antibiotic in the treatment of bacterial infections. It is available in both generic and brand-name formulations. The market for dihydrostreptomycin is highly competitive, with several major pharmaceutical companies producing the drug.
Some of the companies in the dihydrostreptomycin market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Novartis. Show Less Read more